Debrisoquine

Debrisoquine is a drug used to treat hypertension (high blood pressure). It works by blocking certain receptors in the body that cause the blood vessels to constrict, thus reducing the pressure on the walls of the vessels and allowing the blood to flow more freely. Debrisoquine is usually taken orally in the form of tablets or capsules. It is typically prescribed along with lifestyle changes such as diet, exercise, and smoking cessation to help reduce overall blood pressure levels.

Debrisoquine is not a medication currently used in mainstream medicine. Here's why:

  • Historical Use: Debrisoquine was once used as a medication to lower high blood pressure (hypertension). It belonged to a class of drugs called adrenergic blockers.
  • Discontinuation: Debrisoquine was withdrawn from the market due to a significant side effect. It has a pharmacogenetic effect, meaning a person's genes determine how they respond to the medication. Individuals with a specific genetic variation experienced a dangerous drop in blood pressure upon exposure to certain medications or foods containing tyramine, an amino acid.
  • Alternatives: Today, there are numerous safe and effective medications available for treating high blood pressure. These medications have predictable effects and do not require complex genetic testing.

Current Significance:

  • Pharmacogenetics Research: The story of Debrisoquine is a significant case study in pharmacogenetics. It highlights the importance of considering an individual's genetic makeup when developing and prescribing medications.
  • Diagnostic Tool: The Debrisoquine metabolism test was once used to identify individuals at risk for the severe blood pressure drop side effect. However, with the withdrawal of Debrisoquine, this test is no longer routinely used.
Anatomical Therapeutic Chemical Classification
C - Cardiovascular system
C02 Antihypertensives
C02C - Antiadrenergic agents, peripherally acting
C02CC Guanidine derivatives
External Links